Literature DB >> 24061872

[Increased intracranial pressure and brain edema].

W Dietrich1, F Erbguth.   

Abstract

In primary and secondary brain diseases, increasing volumes of the three compartments of brain tissue, cerebrospinal fluid, or blood lead to a critical increase in intracranial pressure (ICP). A rising ICP is associated with typical clinical symptoms; however, during analgosedation it can only be detected by invasive ICP monitoring. Other neuromonitoring procedures are not as effective as ICP monitoring; they reflect the ICP changes and their complications by other metabolic and oxygenation parameters. The most relevant parameter for brain perfusion is cerebral perfusion pressure (CPP), which is calculated as the difference between the middle arterial pressure (MAP) and the ICP. A mixed body of evidence exists for the different ICP-reducing treatment measures, such as hyperventilation, hyperosmolar substances, hypothermia, glucocorticosteroids, CSF drainage, and decompressive surgery.

Entities:  

Mesh:

Year:  2013        PMID: 24061872     DOI: 10.1007/s00101-013-2236-0

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  19 in total

1.  Lack of effect of induction of hypothermia after acute brain injury.

Authors:  G L Clifton; E R Miller; S C Choi; H S Levin; S McCauley; K R Smith; J P Muizelaar; F C Wagner; D W Marion; T G Luerssen; R M Chesnut; M Schwartz
Journal:  N Engl J Med       Date:  2001-02-22       Impact factor: 91.245

Review 2.  [Intracranial hypertension in various brain diseases - Specific therapy and outcome].

Authors:  Farid Salih; Christoph Rosenthal; Stefan Wolf
Journal:  Anasthesiol Intensivmed Notfallmed Schmerzther       Date:  2012-01-27       Impact factor: 0.698

3.  [Intracranial hypertension - Therapeutic options].

Authors:  Christoph Rosenthal; Stefan Wolf; Steffen Weber-Carstens; Farid Salih
Journal:  Anasthesiol Intensivmed Notfallmed Schmerzther       Date:  2012-01-27       Impact factor: 0.698

4.  Guidelines for the management of severe traumatic brain injury. VIII. Intracranial pressure thresholds.

Authors:  Susan L Bratton; Randall M Chestnut; Jamshid Ghajar; Flora F McConnell Hammond; Odette A Harris; Roger Hartl; Geoffrey T Manley; Andrew Nemecek; David W Newell; Guy Rosenthal; Joost Schouten; Lori Shutter; Shelly D Timmons; Jamie S Ullman; Walter Videtta; Jack E Wilberger; David W Wright
Journal:  J Neurotrauma       Date:  2007       Impact factor: 5.269

5.  Decompressive hemicraniectomy for the treatment of intractable intracranial hypertension after aneurysmal subarachnoid hemorrhage.

Authors:  Clemens M Schirmer; Daniel A Hoit; Adel M Malek
Journal:  Stroke       Date:  2007-02-01       Impact factor: 7.914

6.  [EuroHYP-1 trial: EU-funded therapy study on the effectiveness of mild therapeutic hypothermia for acute ischemic stroke].

Authors:  R Kollmar; B Gebhardt; S Schwab
Journal:  Nervenarzt       Date:  2012-10       Impact factor: 1.214

7.  Decompressive craniectomy in diffuse traumatic brain injury.

Authors:  D James Cooper; Jeffrey V Rosenfeld; Lynnette Murray; Yaseen M Arabi; Andrew R Davies; Paul D'Urso; Thomas Kossmann; Jennie Ponsford; Ian Seppelt; Peter Reilly; Rory Wolfe
Journal:  N Engl J Med       Date:  2011-03-25       Impact factor: 91.245

Review 8.  Corticosteroids for acute bacterial meningitis.

Authors:  Matthijs C Brouwer; Peter McIntyre; Jan de Gans; Kameshwar Prasad; Diederik van de Beek
Journal:  Cochrane Database Syst Rev       Date:  2010-09-08

Review 9.  Hypothermia treatment for traumatic brain injury: a systematic review and meta-analysis.

Authors:  Kim Peterson; Susan Carson; Nancy Carney
Journal:  J Neurotrauma       Date:  2008-01       Impact factor: 5.269

10.  European society of intensive care medicine study of therapeutic hypothermia (32-35 °C) for intracranial pressure reduction after traumatic brain injury (the Eurotherm3235Trial).

Authors:  Peter J D Andrews; Helen Louise Sinclair; Claire G Battison; Kees H Polderman; Giuseppe Citerio; Luciana Mascia; Bridget A Harris; Gordon D Murray; Nino Stocchetti; David K Menon; Haleema Shakur; Daniel De Backer
Journal:  Trials       Date:  2011-01-12       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.